世界の心筋症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cardiomyopathy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1129
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、心筋症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（拡張型心筋症、肥大型心筋症、拘束型心筋症）、用途別市場規模（病院・診断センター、外来サービスセンター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・心筋症の市場動向
・企業の競争状況、市場シェア
・心筋症の種類別市場規模（拡張型心筋症、肥大型心筋症、拘束型心筋症）
・心筋症の用途別市場規模（病院・診断センター、外来サービスセンター）
・心筋症の北米市場規模2016-2027（アメリカ、カナダ）
・心筋症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・心筋症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心筋症の中南米市場規模2016-2027（メキシコ、ブラジル）
・心筋症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Array BioPharma、Boston Scientific、Cisbio、Covance、Critical Diagnostics、Mylan、Pfizer、Becton Dickinson、BG Medicine、BioMerieux、Bio-Rad）
・結論

Market Analysis and Insights: Global Cardiomyopathy Market
The global Cardiomyopathy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiomyopathy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiomyopathy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiomyopathy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiomyopathy market.

Global Cardiomyopathy Scope and Market Size
Cardiomyopathy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiomyopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy

Segment by Application
Hospitals and diagnostic centers
Ambulatory services centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Array BioPharma
Boston Scientific
Cisbio
Covance
Critical Diagnostics
Mylan
Pfizer
Becton Dickinson
BG Medicine

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiomyopathy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dilated cardiomyopathy
1.2.3 Hypertrophic cardiomyopathy
1.2.4 Restrictive cardiomyopathy
1.3 Market by Application
1.3.1 Global Cardiomyopathy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and diagnostic centers
1.3.3 Ambulatory services centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cardiomyopathy Market Perspective (2016-2027)
2.2 Cardiomyopathy Growth Trends by Regions
2.2.1 Cardiomyopathy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cardiomyopathy Historic Market Share by Regions (2016-2021)
2.2.3 Cardiomyopathy Forecasted Market Size by Regions (2022-2027)
2.3 Cardiomyopathy Industry Dynamic
2.3.1 Cardiomyopathy Market Trends
2.3.2 Cardiomyopathy Market Drivers
2.3.3 Cardiomyopathy Market Challenges
2.3.4 Cardiomyopathy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cardiomyopathy Players by Revenue
3.1.1 Global Top Cardiomyopathy Players by Revenue (2016-2021)
3.1.2 Global Cardiomyopathy Revenue Market Share by Players (2016-2021)
3.2 Global Cardiomyopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cardiomyopathy Revenue
3.4 Global Cardiomyopathy Market Concentration Ratio
3.4.1 Global Cardiomyopathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiomyopathy Revenue in 2020
3.5 Cardiomyopathy Key Players Head office and Area Served
3.6 Key Players Cardiomyopathy Product Solution and Service
3.7 Date of Enter into Cardiomyopathy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiomyopathy Breakdown Data by Type
4.1 Global Cardiomyopathy Historic Market Size by Type (2016-2021)
4.2 Global Cardiomyopathy Forecasted Market Size by Type (2022-2027)

5 Cardiomyopathy Breakdown Data by Application
5.1 Global Cardiomyopathy Historic Market Size by Application (2016-2021)
5.2 Global Cardiomyopathy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cardiomyopathy Market Size (2016-2027)
6.2 North America Cardiomyopathy Market Size by Type
6.2.1 North America Cardiomyopathy Market Size by Type (2016-2021)
6.2.2 North America Cardiomyopathy Market Size by Type (2022-2027)
6.2.3 North America Cardiomyopathy Market Size by Type (2016-2027)
6.3 North America Cardiomyopathy Market Size by Application
6.3.1 North America Cardiomyopathy Market Size by Application (2016-2021)
6.3.2 North America Cardiomyopathy Market Size by Application (2022-2027)
6.3.3 North America Cardiomyopathy Market Size by Application (2016-2027)
6.4 North America Cardiomyopathy Market Size by Country
6.4.1 North America Cardiomyopathy Market Size by Country (2016-2021)
6.4.2 North America Cardiomyopathy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cardiomyopathy Market Size (2016-2027)
7.2 Europe Cardiomyopathy Market Size by Type
7.2.1 Europe Cardiomyopathy Market Size by Type (2016-2021)
7.2.2 Europe Cardiomyopathy Market Size by Type (2022-2027)
7.2.3 Europe Cardiomyopathy Market Size by Type (2016-2027)
7.3 Europe Cardiomyopathy Market Size by Application
7.3.1 Europe Cardiomyopathy Market Size by Application (2016-2021)
7.3.2 Europe Cardiomyopathy Market Size by Application (2022-2027)
7.3.3 Europe Cardiomyopathy Market Size by Application (2016-2027)
7.4 Europe Cardiomyopathy Market Size by Country
7.4.1 Europe Cardiomyopathy Market Size by Country (2016-2021)
7.4.2 Europe Cardiomyopathy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cardiomyopathy Market Size (2016-2027)
8.2 Asia-Pacific Cardiomyopathy Market Size by Type
8.2.1 Asia-Pacific Cardiomyopathy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cardiomyopathy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cardiomyopathy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cardiomyopathy Market Size by Application
8.3.1 Asia-Pacific Cardiomyopathy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cardiomyopathy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cardiomyopathy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cardiomyopathy Market Size by Region
8.4.1 Asia-Pacific Cardiomyopathy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cardiomyopathy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cardiomyopathy Market Size (2016-2027)
9.2 Latin America Cardiomyopathy Market Size by Type
9.2.1 Latin America Cardiomyopathy Market Size by Type (2016-2021)
9.2.2 Latin America Cardiomyopathy Market Size by Type (2022-2027)
9.2.3 Latin America Cardiomyopathy Market Size by Type (2016-2027)
9.3 Latin America Cardiomyopathy Market Size by Application
9.3.1 Latin America Cardiomyopathy Market Size by Application (2016-2021)
9.3.2 Latin America Cardiomyopathy Market Size by Application (2022-2027)
9.3.3 Latin America Cardiomyopathy Market Size by Application (2016-2027)
9.4 Latin America Cardiomyopathy Market Size by Country
9.4.1 Latin America Cardiomyopathy Market Size by Country (2016-2021)
9.4.2 Latin America Cardiomyopathy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cardiomyopathy Market Size (2016-2027)
10.2 Middle East & Africa Cardiomyopathy Market Size by Type
10.2.1 Middle East & Africa Cardiomyopathy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cardiomyopathy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cardiomyopathy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cardiomyopathy Market Size by Application
10.3.1 Middle East & Africa Cardiomyopathy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cardiomyopathy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cardiomyopathy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cardiomyopathy Market Size by Country
10.4.1 Middle East & Africa Cardiomyopathy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cardiomyopathy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Array BioPharma
11.1.1 Array BioPharma Company Details
11.1.2 Array BioPharma Business Overview
11.1.3 Array BioPharma Cardiomyopathy Introduction
11.1.4 Array BioPharma Revenue in Cardiomyopathy Business (2016-2021)
11.1.5 Array BioPharma Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Cardiomyopathy Introduction
11.2.4 Boston Scientific Revenue in Cardiomyopathy Business (2016-2021)
11.2.5 Boston Scientific Recent Development
11.3 Cisbio
11.3.1 Cisbio Company Details
11.3.2 Cisbio Business Overview
11.3.3 Cisbio Cardiomyopathy Introduction
11.3.4 Cisbio Revenue in Cardiomyopathy Business (2016-2021)
11.3.5 Cisbio Recent Development
11.4 Covance
11.4.1 Covance Company Details
11.4.2 Covance Business Overview
11.4.3 Covance Cardiomyopathy Introduction
11.4.4 Covance Revenue in Cardiomyopathy Business (2016-2021)
11.4.5 Covance Recent Development
11.5 Critical Diagnostics
11.5.1 Critical Diagnostics Company Details
11.5.2 Critical Diagnostics Business Overview
11.5.3 Critical Diagnostics Cardiomyopathy Introduction
11.5.4 Critical Diagnostics Revenue in Cardiomyopathy Business (2016-2021)
11.5.5 Critical Diagnostics Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Cardiomyopathy Introduction
11.6.4 Mylan Revenue in Cardiomyopathy Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Cardiomyopathy Introduction
11.7.4 Pfizer Revenue in Cardiomyopathy Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Details
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Cardiomyopathy Introduction
11.8.4 Becton Dickinson Revenue in Cardiomyopathy Business (2016-2021)
11.8.5 Becton Dickinson Recent Development
11.9 BG Medicine
11.9.1 BG Medicine Company Details
11.9.2 BG Medicine Business Overview
11.9.3 BG Medicine Cardiomyopathy Introduction
11.9.4 BG Medicine Revenue in Cardiomyopathy Business (2016-2021)
11.9.5 BG Medicine Recent Development
11.10 BioMerieux
11.10.1 BioMerieux Company Details
11.10.2 BioMerieux Business Overview
11.10.3 BioMerieux Cardiomyopathy Introduction
11.10.4 BioMerieux Revenue in Cardiomyopathy Business (2016-2021)
11.10.5 BioMerieux Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Details
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad Cardiomyopathy Introduction
11.11.4 Bio-Rad Revenue in Cardiomyopathy Business (2016-2021)
11.11.5 Bio-Rad Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cardiomyopathy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dilated cardiomyopathy
Table 3. Key Players of Hypertrophic cardiomyopathy
Table 4. Key Players of Restrictive cardiomyopathy
Table 5. Global Cardiomyopathy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cardiomyopathy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cardiomyopathy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cardiomyopathy Market Share by Regions (2016-2021)
Table 9. Global Cardiomyopathy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cardiomyopathy Market Share by Regions (2022-2027)
Table 11. Cardiomyopathy Market Trends
Table 12. Cardiomyopathy Market Drivers
Table 13. Cardiomyopathy Market Challenges
Table 14. Cardiomyopathy Market Restraints
Table 15. Global Cardiomyopathy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cardiomyopathy Market Share by Players (2016-2021)
Table 17. Global Top Cardiomyopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiomyopathy as of 2020)
Table 18. Ranking of Global Top Cardiomyopathy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cardiomyopathy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cardiomyopathy Product Solution and Service
Table 22. Date of Enter into Cardiomyopathy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cardiomyopathy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cardiomyopathy Revenue Market Share by Type (2016-2021)
Table 26. Global Cardiomyopathy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cardiomyopathy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cardiomyopathy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cardiomyopathy Revenue Market Share by Application (2016-2021)
Table 30. Global Cardiomyopathy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cardiomyopathy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cardiomyopathy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cardiomyopathy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cardiomyopathy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cardiomyopathy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cardiomyopathy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cardiomyopathy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cardiomyopathy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cardiomyopathy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cardiomyopathy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cardiomyopathy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cardiomyopathy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cardiomyopathy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cardiomyopathy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cardiomyopathy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cardiomyopathy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cardiomyopathy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cardiomyopathy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cardiomyopathy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cardiomyopathy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cardiomyopathy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cardiomyopathy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cardiomyopathy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cardiomyopathy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cardiomyopathy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cardiomyopathy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cardiomyopathy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cardiomyopathy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cardiomyopathy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cardiomyopathy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cardiomyopathy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Array BioPharma Company Details
Table 63. Array BioPharma Business Overview
Table 64. Array BioPharma Cardiomyopathy Product
Table 65. Array BioPharma Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 66. Array BioPharma Recent Development
Table 67. Boston Scientific Company Details
Table 68. Boston Scientific Business Overview
Table 69. Boston Scientific Cardiomyopathy Product
Table 70. Boston Scientific Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 71. Boston Scientific Recent Development
Table 72. Cisbio Company Details
Table 73. Cisbio Business Overview
Table 74. Cisbio Cardiomyopathy Product
Table 75. Cisbio Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 76. Cisbio Recent Development
Table 77. Covance Company Details
Table 78. Covance Business Overview
Table 79. Covance Cardiomyopathy Product
Table 80. Covance Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 81. Covance Recent Development
Table 82. Critical Diagnostics Company Details
Table 83. Critical Diagnostics Business Overview
Table 84. Critical Diagnostics Cardiomyopathy Product
Table 85. Critical Diagnostics Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 86. Critical Diagnostics Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Cardiomyopathy Product
Table 90. Mylan Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Cardiomyopathy Product
Table 95. Pfizer Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Becton Dickinson Company Details
Table 98. Becton Dickinson Business Overview
Table 99. Becton Dickinson Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 100. Becton Dickinson Recent Development
Table 101. BG Medicine Company Details
Table 102. BG Medicine Business Overview
Table 103. BG Medicine Cardiomyopathy Product
Table 104. BG Medicine Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 105. BG Medicine Recent Development
Table 106. BioMerieux Company Details
Table 107. BioMerieux Business Overview
Table 108. BioMerieux Cardiomyopathy Product
Table 109. BioMerieux Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 110. BioMerieux Recent Development
Table 111. Bio-Rad Company Details
Table 112. Bio-Rad Business Overview
Table 113. Bio-Rad Cardiomyopathy Product
Table 114. Bio-Rad Revenue in Cardiomyopathy Business (2016-2021) & (US$ Million)
Table 115. Bio-Rad Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiomyopathy Market Share by Type: 2020 VS 2027
Figure 2. Dilated cardiomyopathy Features
Figure 3. Hypertrophic cardiomyopathy Features
Figure 4. Restrictive cardiomyopathy Features
Figure 5. Global Cardiomyopathy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals and diagnostic centers Case Studies
Figure 7. Ambulatory services centers Case Studies
Figure 8. Cardiomyopathy Report Years Considered
Figure 9. Global Cardiomyopathy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cardiomyopathy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cardiomyopathy Market Share by Regions: 2020 VS 2027
Figure 12. Global Cardiomyopathy Market Share by Regions (2022-2027)
Figure 13. Global Cardiomyopathy Market Share by Players in 2020
Figure 14. Global Top Cardiomyopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiomyopathy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cardiomyopathy Revenue in 2020
Figure 16. Global Cardiomyopathy Revenue Market Share by Type (2016-2021)
Figure 17. Global Cardiomyopathy Revenue Market Share by Type (2022-2027)
Figure 18. North America Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cardiomyopathy Market Share by Type (2016-2027)
Figure 20. North America Cardiomyopathy Market Share by Application (2016-2027)
Figure 21. North America Cardiomyopathy Market Share by Country (2016-2027)
Figure 22. United States Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cardiomyopathy Market Share by Type (2016-2027)
Figure 26. Europe Cardiomyopathy Market Share by Application (2016-2027)
Figure 27. Europe Cardiomyopathy Market Share by Country (2016-2027)
Figure 28. Germany Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cardiomyopathy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cardiomyopathy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cardiomyopathy Market Share by Region (2016-2027)
Figure 38. China Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cardiomyopathy Market Share by Type (2016-2027)
Figure 46. Latin America Cardiomyopathy Market Share by Application (2016-2027)
Figure 47. Latin America Cardiomyopathy Market Share by Country (2016-2027)
Figure 48. Mexico Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cardiomyopathy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cardiomyopathy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cardiomyopathy Market Share by Country (2016-2027)
Figure 54. Turkey Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cardiomyopathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Array BioPharma Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 58. Boston Scientific Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 59. Cisbio Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 60. Covance Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 61. Critical Diagnostics Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 64. Becton Dickinson Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 65. BG Medicine Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 66. BioMerieux Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 67. Bio-Rad Revenue Growth Rate in Cardiomyopathy Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の肥大型心筋症治療市場規模・現状・予測（2021年-2027年）

Global Hypertrophic Cardiomyopathy Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3004 2021年4月 94Pages
QYResearch社発行の本調査資料では、肥大型心筋症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルシウムチャネル遮断薬、抗不整脈薬、βアドレナリン遮断薬、抗凝固薬、その他）、用途別市場規模（病院、診療所、外来手術センター、学術・研...

世界の心筋症装置市場規模・現状・予測（2021年-2027年）

Global Cardiomyopathy Devices Market Size, Status and Forecast 2021-2027
QYR2104Z1128 2021年4月 94Pages
QYResearch社発行の本調査資料では、心筋症装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断装置、治療装置）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界の拡張型心筋症治療市場規模・現状・予測（2021年-2027年）

Global Dilated Cardiomyopathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1896 2021年4月 93Pages
QYResearch社発行の本調査資料では、拡張型心筋症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬剤、植込み型除細動器）、用途別市場規模（子供、成人、高齢者）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の肥大型心筋症（HCM）治療市場規模・現状・予測（2021年-2027年）

Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3003 2021年4月 98Pages
QYResearch社発行の本調査資料では、肥大型心筋症（HCM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（βアドレナリン遮断薬、カルシウムチャネル遮断薬、抗不整脈薬、抗凝固薬、その他）、用途別市場規模（病院薬局、小売薬局）、主要地域...

世界のトランスサイレチンアミロイド心筋症（ATTR-CM）治療市場規模・現状・予測（2021年-2027年）

Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5731 2021年4月 91Pages
QYResearch社発行の本調査資料では、トランスサイレチンアミロイド心筋症（ATTR-CM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トランスサイレチン安定剤、非ステロイド性抗炎症薬（NSAID）、RNAi療法、その他）、用途別市...

世界のクロファラビン市場規模・現状・予測（2021年-2027年）

Global Clofarabine Market Size, Status and Forecast 2021-2027
QYR2104Z1384 2021年4月 99Pages
QYResearch社発行の本調査資料では、クロファラビンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エボルトラ、クロファラビン）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

Global Micafungin Sodium for Injection Market Size, Status and Forecast 2021-2027
QYR2104Z3743 2021年4月 97Pages
QYResearch社発行の本調査資料では、注射用ミカファンギンナトリウムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（50mg使い捨てバイアル、100mg使い捨てバイアル）、用途別市場規模（カンジダ血症、呼吸器真菌症、胃腸真菌症）、主要地域...

世界のエキソストシン1/2ヘテロダイマー市場規模・現状・予測（2021年-2027年）

Global Exostosin 1/2 Heterodimer Market Size, Status and Forecast 2021-2027
QYR2104Z2272 2021年4月 92Pages
QYResearch社発行の本調査資料では、エキソストシン1/2ヘテロダイマーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

世界の肥大型心筋症治療市場規模・現状・予測（2021年-2027年） HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
世界の拡張型心筋症治療市場規模・現状・予測（2021年-2027年） Dilated Cardiomyopathy (DCM) is a condition in which heart's left ventricle, is enlarged and weakened and the ability to pump blood is decreased. The growth in DCM treatment market is due to prominent rise in number of heart failure patients worldwide over the years, R&D activities and increased awa…
世界の肥大型心筋症（HCM）治療市場規模・現状・予測（2021年-2027年） Hypertrophic Cardiomyopathy (HCM) is a condition in which a portion of the heart becomes thickened without an obvious cause. This results in the heart being less able to pump blood effectively. Symptoms vary from none to feeling tired, leg swelling, and shortness of breath. It may also result in che…
世界の心筋症装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cardiomyopathy Devices Market The global Cardiomyopathy Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
世界のトランスサイレチンアミロイド心筋症（ATTR-CM）治療市場規模・現状・予測（2021年-2027年） Transthyretin Amyloidosis (ATTR) is a progressive and severe orphan disease. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of transthyretin amyloidosis (ATTR) that affects the heart and leads to restrictive cardiomyopathy and progressive heart failure. It is generally a rare, underdiagnos…